Iovance comes back with another upbeat cancer trial update as #ASCO19 curtain raiser
Iovance, one of the new darlings of the cancer set, pulled off the curtain raiser at ASCO with an update that offers another encouraging snapshot of progress and potential for its I/O drugs.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.